home / stock / hltrf / hltrf quote
Last: | $3.85 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $3.85 |
High: | $0 |
Low: | $0 |
Volume: | 102 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$3.85 | $0 | $3.85 | $0 | $0 | 102 | 04-16-2024 |
$3.85 | $3.85 | $3.85 | $3.85 | $3.85 | 2,000 | 04-09-2024 |
$4 | $3.95 | $4 | $4 | $3.95 | 1,300 | 04-08-2024 |
$3.1109 | $0 | $3.1109 | $0 | $0 | 100 | 04-04-2024 |
$3.1109 | $0 | $3.1109 | $0 | $0 | 100 | 04-01-2024 |
$3.1109 | $0 | $3.1109 | $0 | $0 | 100 | 03-18-2024 |
$3.1109 | $0 | $3.1109 | $0 | $0 | 100 | 03-15-2024 |
$3.1109 | $0 | $3.1109 | $0 | $0 | 100 | 03-14-2024 |
$3.1109 | $0 | $3.1109 | $0 | $0 | 100 | 03-12-2024 |
$3.1109 | $3.1183 | $3.1109 | $3.1183 | $3.1109 | 1,498 | 03-08-2024 |
$3.19 | $0 | $3.19 | $0 | $0 | 18 | 02-15-2024 |
$3.19 | $0 | $3.19 | $0 | $0 | 100 | 02-01-2024 |
$3.19 | $0 | $3.19 | $0 | $0 | 2,625 | 01-30-2024 |
$3.19 | $3.19 | $3.19 | $3.19 | $3.19 | 100 | 01-29-2024 |
$3.84 | $0 | $3.84 | $0 | $0 | 100 | 01-23-2024 |
$3.84 | $3.84 | $3.84 | $3.84 | $3.84 | 300 | 12-28-2023 |
$2.77 | $2.77 | $2.77 | $2.77 | $2.77 | 1,400 | 12-27-2023 |
$2.73 | $2.73 | $2.73 | $2.73 | $2.73 | 1,500 | 12-20-2023 |
$2.7433 | $0 | $2.7433 | $0 | $0 | 50 | 12-14-2023 |
$2.7433 | $0 | $2.7433 | $0 | $0 | 8 | 12-11-2023 |
News, Short Squeeze, Breakout and More Instantly...
HLS Therapeutics Inc Company Name:
HLTRF Stock Symbol:
OTCMKTS Market:
HLS Therapeutics Announces First Quarter Fiscal 2021 Financial Results Canada NewsWire Q1 2021 revenue of $14.3 million , Adjusted EBITDA of $6.7 million and cash from operations of $7.2 million , up $0.4 million , $0.6 million and $1.8 million ...
HLS Therapeutics to Host Q1 2021 Financial Results Conference Call Canada NewsWire TORONTO , April 22, 2021 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), announces that it will release its Q1 2021 financial results on Thursday, May 6, 2021 ...
HLS Therapeutics Announces Participation in Upcoming Conferences Canada NewsWire TORONTO , April 15, 2021 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), a specialty pharmaceutical company focused on central nervous system and cardiovascular ma...